Autophagy is a process by which cellular components are captured into organelles called autophagosomes and then brought to the lysosome or vacuole to be broken down and recycled for other uses. It frequently comes into play during starvation, allowing cells to survive periods of privation.Yoshinori Ohsumi survived privation while growing up in post–World War II Japan and struggled to establish his own course of independent research. But he persevered and went on to make key early discoveries in the field of autophagy (1, 2). In his work, he has identified most of the proteins and pathways involved in the process (3), demonstrated how they are regulated by proteins that sense cells’ metabolic states (4), and started to outline the fine mechanistic details of autophagosome formation in yeast (5, 6). In spite of all his successes, he was surprised by our request for an interview but nevertheless happy to speak with us about his work from his office at Tokyo Institute of Technology.Yoshinori OhsumiPHOTO COURTESY OF YOSHINORI OHSUMI“We realized we had almost the entire pathway in our hands.”
EARLY LEAPS
How did you decide to go into a research career?I was probably influenced by my father, who was a professor of engineering at Kyushu University. I was familiar with academic life while I was growing up. But whereas my father worked in a very industrially oriented field, I was more interested in the natural sciences. In high school I was interested in chemistry, so I entered the University of Tokyo to learn chemistry. I quickly discovered chemistry wasn't so attractive to me, because the field was already quite established. But I was lucky, I think, because the early 1960s was the golden age of molecular biology. I decided I wanted to work on that instead.There were not very many molecular biology labs in Japan at that time. I joined Dr. Kazutomo Imahori's lab as a graduate student to study protein synthesis in E. coli. Unfortunately, I did not get very good results in my work, and, when I had finished my graduate studies, I discovered it was very difficult to find a good position in Japan. So, on Dr. Imahori's advice, I took a postdoctoral position with Dr. Gerald Edelman at The Rockefeller University in New York.What did you work on there?That was the hardest time in my life. [Laughs] As a graduate student I had worked on E. coli, but in Dr. Edelman's lab I switched to working on mammalian cell and developmental biology. I was supposed to establish a system for in vitro fertilization in mice, but I did not know very much about early embryology and I had only a very small number of eggs to work with. I grew very frustrated. Then, one and a half years later, Mike Jazwinski joined Edelman's lab, and I decided to work with him instead on studying DNA duplication in yeast. That was another huge leap for me, but it was also my first introduction to yeast cells, which I have worked with ever since.Finally, I was offered a position as a junior professor in Yasuhiro Anraku's lab at the University of Tokyo and was able to return to Japan.
You also characterized many of the genes involved in autophagy…In 1991, one of my first two graduate students—a wonderful student—performed a very laborious screen, observing individual mutants under the microscope. Using this approach, she found the first autophagy-defective mutant, which at the time we called apg1-1 but is now called atg1. I expected that we could use this type of screen to find many more autophagy genes, because autophagy is such a complex phenomenon, and, indeed, we found 14 atg mutants in this way.I had quite a small lab, only three people, when we started the genetic analysis of ATG genes. I was afraid it would take a very long time to complete our analysis, but the yeast genome sequence was published around that time, so we were able to quickly clone many of the genes. But except for ATG1, which encodes a protein kinase, all the other ATG genes were novel genes; their amino acid sequence did not tell us very much about what they did.One breakthrough was made by Noboru Mizushima, a medical doctor who joined my lab as a postdoc. He showed that Atg12 is a ubiquitin-like protein that is conjugated to Atg5. Atg7 is an E1 enzyme, and Atg10 is an E2 enzyme, so we realized we had almost the entire pathway in our hands. We published that result in Nature without any serious objections, and that was the first major success in my lab. [Laughs] There is also another, similar pathway that results in the addition of Atg8, another ubiquitin-like protein, to the phospholipidphosphatidylethanolamine.Ohsumi worked alone in his first lab; now he has plenty of company.PHOTO COURTESY OF YOSHINORI OHSUMI“I am not very competitive, so I always look for a new subject to study, even if it is not so popular.”We now have a better understanding of what the individual Atg proteins do, but we still don't understand how they drive autophagosome formation. We want to understand how new autophagosomal membrane appears, how it elongates, and how it seals to become an autophagosome. We are also working to analyze the structural biology of Atg proteins and to understand how they interact with each other to form complexes. These complexes are very transient, so it is difficult to study them. Those are the basic questions we're working on now.Do you have advice for scientists who are struggling, as you did early in your career?Unfortunately, these days, at least in Japan, young scientists want to get a stable job, so they are afraid to take risks. Most people decide to work on the most popular field because they think that is the easiest way to get a paper published. But I am just the opposite of that. I am not very competitive, so I always look for a new subject to study, even if it is not so popular. If you start from some sort of basic, new observation, you will have plenty to work on.
Authors: N Mizushima; T Noda; T Yoshimori; Y Tanaka; T Ishii; M D George; D J Klionsky; M Ohsumi; Y Ohsumi Journal: Nature Date: 1998-09-24 Impact factor: 49.962
Authors: Rui Zhang; Monica Varela; Gabriel Forn-Cuní; Vincenzo Torraca; Michiel van der Vaart; Annemarie H Meijer Journal: Cell Death Dis Date: 2020-04-24 Impact factor: 8.469